Close

Biomarin Pharma (BMRN) Tops Q3 EPS by 7c; Tightens FY10 Guidance

October 28, 2010 4:26 PM EDT Send to a Friend
Biomarin Pharma (Nasdaq: BMRN) reports Q3 EPS of $0.06, 7 cents ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login